Pfizer asks district court to exclude expert testimony in competition case

29-05-2017

Pfizer asks district court to exclude expert testimony in competition case

no_limit_pictures / iStockphoto.com

Pfizer has filed a motion to exclude a declaration and testimony supporting a class of direct purchasers that have accused it of anti-competitive conduct.


Pfizer, expert testimony, competition, patent, class action, generic, Celebrex, USPTO

LSIPR